サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：次世代シーケンシングサービス市場-世界の産業規模、シェア、動向、機会、および予測、2018年～2028年
市場調査レポート
商品コード
1326508

次世代シーケンシングサービス市場-世界の産業規模、シェア、動向、機会、および予測、2018年～2028年

Next Generation Sequencing Services Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Service, By Workflow, By End User, By Region and Competition
出版日: | 発行: TechSci Research | ページ情報: 英文 112 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円

こちらのレポートには、数時間（ご購入金額の10%）分のアナリストへの質問／追加調査サービスが含まれております。

次世代シーケンシングサービス市場-世界の産業規模、シェア、動向、機会、および予測、2018年～2028年
出版日: 2023年08月01日
発行: TechSci Research
ページ情報: 英文 112 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 目次
概要

次世代シーケンシングサービスの世界市場は、予測期間2024～2028年に目覚ましい成長が見込まれます。

この成長の背景には、ゲノム技術の進歩、精密医療に対する需要の増加、臨床研究における次世代シーケンシングの応用拡大、遺伝性疾患の有病率の増加があります。

新興諸国におけるNGS採用の増加

新興諸国における次世代シーケンシング（NGS）技術の採用は、近年着実に増加しています。この動向は今後も続くと予想され、NGS市場の成長に大きな影響を与えるでしょう。新興諸国におけるNGSの採用を促進する主な要因の1つは、より良いヘルスケアサービスに対する需要の高まりです。NGS技術は、遺伝子疾患、がん、感染症など、さまざまな疾患の診断と治療を改善する可能性を秘めています。新興諸国はこれらの疾患による負担の増大に直面しているため、NGSは彼らのヘルスケアシステムにとって不可欠なツールになりつつあります。

さらに、NGS技術のコストが低下し、手頃な価格のシーケンスプラットフォームが利用できるようになったことで、新興諸国はこの技術を採用しやすくなっています。さらに、新興諸国の多くの政府は、NGSのような先進技術の採用を含むヘルスケアインフラの整備に投資しています。新興諸国におけるNGS導入の増加は、今後数年間のNGS市場成長の主な促進要因になると予想されます。より良いヘルスケアサービスに対する需要の高まり、NGS技術のコスト低下、医療インフラへの政府投資がこの動向を後押しする主な要因です。

ゲノム技術の進歩

ゲノム技術の進歩は、今後数年間の次世代シーケンシング（NGS）市場の成長を促進します。ゲノム技術の進化により、DNAとRNAのシーケンスをより速いペースで、より高い精度で、より低コストで行うことが可能になりました。これにより、臨床研究、創薬、個別化医療、農業などさまざまな分野でNGS技術が広く採用されるようになっています。

ゲノム技術の著しい進歩のひとつに、ロングリードシーケンス技術の開発があります。ロングリードシーケンスでは、長いDNAおよびRNA断片の完全なシーケンスが可能であり、構造変異、遺伝子融合、代替スプライシングなどの複雑な遺伝子変異を理解するために不可欠です。この技術により、ゲノムアセンブリの精度と完全性が向上し、新たな遺伝子変異の同定が可能になり、疾患の遺伝的基盤の理解が深まっています。

ゲノム技術のもう一つの進歩は、単一細胞シーケンス技術の開発です。この技術によって個々の細胞の解析が可能になり、細胞の不均一性や細胞間相互作用についての洞察が得られます。シングルセルシーケンスは、がん研究、神経生物学、発生生物学など、さまざまな分野で利用されています。その結果、これらの分野でNGS技術に対する需要が高まっています。

さらに、クラウド別のコンピューティングプラットフォームとバイオインフォマティクスツールの開拓により、NGSデータの解析が容易になり、NGS市場の成長につながりました。これらのツールにより、研究者は大規模なゲノムデータセットを迅速かつ効率的に解析できるようになり、新たな発見や患者の転帰改善につながります。

ゲノム技術の進歩が、今後数年間のNGS市場の成長を促進します。ロングリードシーケンス、シングルセルシーケンス、クラウド別のコンピューティングプラットフォームは、NGS市場の将来を形作る重要な進歩の一部です。

遺伝性疾患の有病率の増加

遺伝性疾患の有病率の増加は、今後数年間の次世代シーケンシング（NGS）市場の成長を促進する重要な要因です。遺伝性疾患は個人のDNA配列の異常によって引き起こされ、さまざまな健康問題を引き起こす可能性があります。一般的な遺伝子疾患には、嚢胞性線維症、鎌状赤血球貧血、ハンチントン病などがあります。

NGS技術は、ヒトゲノムの大部分を迅速かつコスト効率よく配列決定することを可能にし、遺伝学の分野に革命をもたらしました。この技術により、様々な遺伝性疾患の原因となる遺伝子変異や変異を同定することが可能になっています。その結果、NGSは遺伝子研究や臨床診断に不可欠なツールとなっています。

遺伝性疾患の有病率の増加が、臨床診断におけるNGS技術の需要を牽引しています。NGS別の遺伝子検査は、遺伝性疾患の患者に正確で包括的な診断を提供することができ、医師はより個別化された効果的な治療計画を提供することができます。さらに、NGS別の遺伝子検査はますます手頃な価格で利用しやすくなっており、より多くの患者がこの技術の恩恵を受けられるようになっています。

臨床診断に加え、NGS技術は遺伝子研究にも利用され、様々な疾患に関連する新たな遺伝子変異や変異を同定しています。この研究は、遺伝性疾患の新しい治療法や治療法の開発に不可欠です。遺伝性疾患の有病率の増加は、今後数年間のNGS市場成長の重要な促進要因になると予想されます。NGS技術は、ヒトゲノムの大部分を迅速かつコスト効率よくシーケンスできるようにすることで遺伝学分野に革命をもたらし、さまざまな遺伝性疾患の原因となる遺伝子変異や変異の特定を可能にしています。

利用可能なカスタマイズ

所定の市場データを用いて、TechSci Researchは企業の特定のニーズに応じてカスタマイズを提供します。レポートでは以下のカスタマイズが可能です：

企業情報

  • 追加市場参入企業（最大5社）の詳細分析とプロファイリング

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 次世代シーケンシングサービスの世界市場展望

  • 市場規模および予測
    • 金額別
  • 市場シェアと予測
    • サービス別
    • ワークフロー別
    • エンドユーザー別
    • 地域別
    • 企業別
  • 製品マップ
    • サービス別
    • ワークフロー別
    • エンドユーザー別
    • 地域別

第6章 北米の次世代シーケンシングサービス市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェアと予測
    • サービス別
    • ワークフロー別
    • エンドユーザー別
    • 国別
  • 北米国別分析
    • 米国
    • カナダ
    • メキシコ

第7章 欧州の次世代シーケンシングサービス市場展望

  • 市場規模および予測
    • 金額別
  • 市場シェアと予測
    • サービス別
    • ワークフロー別
    • エンドユーザー別
    • 国別
  • 欧州国別分析
    • フランス
    • ドイツ
    • 英国
    • イタリア
    • スペイン

第8章 アジア太平洋地域の次世代シーケンシングサービス市場展望

  • 市場規模および予測
    • 金額別
  • 市場シェアと予測
    • サービス別
    • ワークフロー別
    • エンドユーザー別
    • 国別
  • アジア太平洋地域国別分析
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア

第9章 南米の次世代シーケンシングサービス市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェアと予測
    • サービス別
    • ワークフロー別
    • エンドユーザー別
    • 国別
  • 南米：国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第10章 中東・アフリカの次世代シーケンシングサービス市場展望

  • 市場規模および予測
    • 金額別
  • 市場シェアと予測
    • サービス別
    • ワークフロー別
    • エンドユーザー別
    • 国別
  • MEA：国別分析
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦

第11章 市場力学

  • 促進要因
  • 課題

第12章 市場動向と発展

  • 最近の展開
  • 合併・買収
  • 製品発表

第13章 次世代シーケンシングサービスの世界市場SWOT分析

第14章 ポーターのファイブフォース分析

  • 業界内の競合
  • 新規参入の可能性
  • サプライヤーの力
  • 顧客の力
  • 代替品の脅威

第15章 競合情勢

  • Business Overview
  • Service Offerings
  • Recent Developments
  • Key Personnel
  • SWOT Analysis
    • Quest Diagnostics Incorporated
    • Applied Biological Materials, Inc.
    • Novogene Co, Ltd.
    • Azenta Life Sciences（GENEWIZ）
    • NanoString Technologies, Inc.
    • Illumina, Inc.
    • PacBio, Inc.
    • Gene by Gene Ltd
    • Lucigen Corporation

第16章 戦略的提言

目次
Product Code: 15173

Global Next Generation Sequencing Services Market is expected to see impressive growth during the forecast period, 2024-2028. This growth is accounted for by advancements in genomic technologies, increasing demand for precision medicine, growing application of next-generation sequencing in clinical research, and increasing prevalence of genetic disorders.

Advancements in genomic technologies have led to the development of more advanced and efficient sequencing platforms, which have reduced the cost and time required for sequencing. This has made NGS more accessible to researchers and has driven the growth of the NGS Services Market.

The demand for precision medicine has increased significantly in recent years as researchers and healthcare providers seek to develop personalized treatments for patients based on their unique genetic makeup. NGS services are essential for identifying genetic variations that may be relevant to disease diagnosis, prognosis, and treatment.

NGS is increasingly being used in clinical research, including clinical trials and diagnostic testing. This has led to a growing demand for NGS services in the clinical research industry.

The increasing prevalence of genetic disorders has driven the growth of the NGS Services Market. NGS can be used to diagnose genetic disorders and identify potential treatments, making it an essential tool for genetic testing and diagnosis.

In the past few years, several new NGS services have been launched in the market. For example, in 2020, Illumina launched the NovaSeq 6000 system, which is designed to offer high-throughput sequencing with low per-sample costs. The system uses innovative flow cells and sequencing reagents to deliver high accuracy and cost-effectiveness, making it an attractive option for large-scale sequencing projects.

Thermo Fisher Scientific launched the Ion GeneStudio S5 system in 2019, which is designed to enable fast and accurate NGS for a range of applications. The system offers a compact and scalable design, making it suitable for a range of settings, from small labs to large-scale research facilities. In 2019, Qiagen launched the QIAseq Targeted RNA Panels, which enable researchers to analyze specific gene targets for RNA sequencing. The panels are designed to be compatible with the company's GeneReader NGS system, allowing for a streamlined workflow from sample to result.

However, the market of next-generation sequencing will face several challenges, including data management and analysis, standardization and quality control, regulatory challenges, cost, and data privacy and security. The biggest challenge associated with NGS services is the sheer volume of data generated by the sequencing process. Processing and analyzing this data can be time-consuming and computationally intensive, requiring specialized software and hardware. In addition, the accuracy of the results can be affected by various factors such as sequencing errors, sample contamination, and reference genome quality.

Standardization and quality control are essential to ensure the accuracy and reliability of NGS results. However, there are currently no universally accepted standards for NGS, and quality control can be challenging due to the high variability of samples and sequencing technologies. There is a need for robust quality control procedures that can be applied across different sequencing platforms and laboratories.

Increasing Adoption of NGS in Developing Countries

The adoption of Next Generation Sequencing (NGS) technology in developing countries has been steadily increasing in recent years. This trend is expected to continue in the coming years, and it will have a significant impact on the growth of the NGS market. One of the major factors driving the adoption of NGS in developing countries is the increasing demand for better healthcare services. NGS technology has the potential to improve the diagnosis and treatment of various diseases, including genetic disorders, cancer, and infectious diseases. As developing countries are facing a growing burden of these diseases, NGS is becoming an essential tool for their healthcare systems.

Moreover, the declining cost of NGS technology and the availability of affordable sequencing platforms are making it easier for developing countries to adopt this technology. Additionally, many governments in developing countries are investing in the development of their healthcare infrastructure, which includes the adoption of advanced technologies like NGS. The increasing adoption of NGS in developing countries is expected to be a major driver for the growth of the NGS market in the coming years. The growing demand for better healthcare services, declining costs of NGS technology, and government investments in healthcare infrastructure are the key factors driving this trend.

Advancements in Genomic Technologies

Advancements in genomic technologies are driving the growth of the Next Generation Sequencing (NGS) Market in the coming years. The evolution of genomic technologies has made it possible to sequence DNA and RNA at a faster pace, with greater accuracy, and at a lower cost. This has led to the widespread adoption of NGS technology in various fields, including clinical research, drug discovery, personalized medicine, and agriculture.

One of the significant advancements in genomic technologies is the development of long-read sequencing technology. Long-read sequencing provides complete sequencing of long DNA and RNA fragments, which is critical for understanding complex genetic variations such as structural variants, gene fusions, and alternative splicing. This technology has improved the accuracy and completeness of genome assemblies, making it possible to identify new genetic variants and improve understanding of the genetic basis of diseases.

Another advancement in genomic technologies is the development of single-cell sequencing technology. This technology allows the analysis of individual cells, providing insight into cellular heterogeneity and cellular interactions. Single-cell sequencing is being used in various fields, including cancer research, neurobiology, and developmental biology. As a result, there is a growing demand for NGS technology in these areas.

In addition, the development of cloud-based computing platforms and bioinformatics tools has made it easier to analyze NGS data, leading to the growth of the NGS market. These tools allow researchers to analyze large-scale genomic data sets quickly and efficiently, leading to new discoveries and improved patient outcomes.

Advancements in genomic technologies are driving the growth of the NGS Market in the coming years. Long-read sequencing, single-cell sequencing, and cloud-based computing platforms are some of the key advancements that are shaping the future of the NGS market.

Increasing Prevalence of Genetic Disorders

The increasing prevalence of genetic disorders is a significant factor driving the growth of the Next Generation Sequencing (NGS) market in the coming years. Genetic disorders are caused by abnormalities in an individual's DNA sequence, and they can result in a wide range of health problems. Some of the common genetic disorders include cystic fibrosis, sickle cell anemia, and Huntington's disease.

NGS technology has revolutionized the field of genetics by allowing for the rapid and cost-effective sequencing of large portions of the human genome. This technology has made it possible to identify the genetic mutations and variations that are responsible for various genetic disorders. As a result, NGS has become an essential tool for genetic research and clinical diagnostics.

The increasing prevalence of genetic disorders is driving the demand for NGS technology in clinical diagnostics. NGS-based genetic testing can provide accurate and comprehensive diagnoses for patients with genetic disorders, enabling doctors to provide more personalized and effective treatment plans. Moreover, NGS-based genetic testing is becoming increasingly affordable and accessible, making it possible for more patients to benefit from this technology.

In addition to clinical diagnostics, NGS technology is being used in genetic research to identify new genetic mutations and variations associated with various diseases. This research is critical for developing new treatments and therapies for genetic disorders. The increasing prevalence of genetic disorders is expected to be a significant driver for the growth of the NGS Market in the coming years. NGS technology has revolutionized the field of genetics by enabling the rapid and cost-effective sequencing of large portions of the human genome, making it possible to identify the genetic mutations and variations responsible for various genetic disorders.

Market Segmentation

Global Next Generation Sequencing Services Market can be segmented based on service, workflow, end user, and region. Based on service, the market can be divided into human genome sequencing services, single-cell sequencing services, microbial genome-based sequencing services, gene regulation services, and others. Based on workflow, the market is divided into pre-sequencing, sequencing, and data analysis. Based on end users, the market is divided into hospitals & clinics, academic & research institutions, pharmaceutical & biotechnology companies, and others. Regionally, the Next Generation Sequencing Services Market can be categorized into North America, Europe, Asia Pacific, South America, and Middle East & Africa.

Market Players

Quest Diagnostics Incorporated, Applied Biological Materials, Inc., Novogene Co, Ltd., Azenta Life Sciences (GENEWIZ), NanoString Technologies, Inc., Illumina, Inc., PacBio, Inc., Gene by Gene Ltd, Lucigen Corporation are some of the leading players operating in the Global Next Generation Sequencing Services Market.

Report Scope:

In this report, Global Next Generation Sequencing Services Market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Next Generation Sequencing Services Market, By Service:

  • Human Genome Sequencing Services
  • Single Cell Sequencing Services
  • Microbial Genome-based Sequencing Services
  • Gene Regulation Services
  • Others

Next Generation Sequencing Services Market, By Workflow:

  • Pre-Sequencing
  • Sequencing
  • Data Analysis

Next Generation Sequencing Services Market, By Workflow:

  • Hospitals & Clinics
  • Academic & Research Institutions
  • Pharmaceutical & Biotechnology Companies
  • Others

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Next Generation Sequencing Services Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validations
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Next Generation Sequencing Services Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Service (Human Genome Sequencing Services, Single Cell Sequencing Services, Microbial Genome-based Sequencing Services, Gene Regulation Services, Others)
    • 5.2.2. By Workflow (Pre-Sequencing, Sequencing, Data Analysis)
    • 5.2.3. By End User (Hospitals & Clinics, Academic & Research Institutions, Pharmaceutical & Biotechnology Companies, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2022)
  • 5.3. Product Map
    • 5.3.1. By Service
    • 5.3.2. By Workflow
    • 5.3.3. By End User
    • 5.3.4. By Region

6. North America Next Generation Sequencing Services Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Service
    • 6.2.2. By Workflow
    • 6.2.3. By End User
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Next Generation Sequencing Services Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Service
        • 6.3.1.2.2. By Workflow
        • 6.3.1.2.3. By End User
    • 6.3.2. Canada Next Generation Sequencing Services Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Service
        • 6.3.2.2.2. By Workflow
        • 6.3.2.2.3. By End User
    • 6.3.3. Mexico Next Generation Sequencing Services Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Service
        • 6.3.3.2.2. By Workflow
        • 6.3.3.2.3. By End User

7. Europe Next Generation Sequencing Services Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Service
    • 7.2.2. By Workflow
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Next Generation Sequencing Services Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Service
        • 7.3.1.2.2. By Workflow
        • 7.3.1.2.3. By End User
    • 7.3.2. Germany Next Generation Sequencing Services Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Service
        • 7.3.2.2.2. By Workflow
        • 7.3.2.2.3. By End User
    • 7.3.3. United Kingdom Next Generation Sequencing Services Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecasty
        • 7.3.3.2.1. By Service
        • 7.3.3.2.2. By Workflow
        • 7.3.3.2.3. By End User
    • 7.3.4. Italy Next Generation Sequencing Services Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Service
        • 7.3.4.2.2. By Workflow
        • 7.3.4.2.3. By End User
    • 7.3.5. Spain Next Generation Sequencing Services Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Service
        • 7.3.5.2.2. By Workflow
        • 7.3.5.2.3. By End User

8. Asia-Pacific Next Generation Sequencing Services Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Service
    • 8.2.2. By Workflow
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Next Generation Sequencing Services Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Service
        • 8.3.1.2.2. By Workflow
        • 8.3.1.2.3. By End User
    • 8.3.2. India Next Generation Sequencing Services Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Service
        • 8.3.2.2.2. By Workflow
        • 8.3.2.2.3. By End User
    • 8.3.3. Japan Next Generation Sequencing Services Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Service
        • 8.3.3.2.2. By Workflow
        • 8.3.3.2.3. By End User
    • 8.3.4. South Korea Next Generation Sequencing Services Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Service
        • 8.3.4.2.2. By Workflow
        • 8.3.4.2.3. By End User
    • 8.3.5. Australia Next Generation Sequencing Services Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Service
        • 8.3.5.2.2. By Workflow
        • 8.3.5.2.3. By End User

9. South America Next Generation Sequencing Services Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Service
    • 9.2.2. By Workflow
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Next Generation Sequencing Services Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Service
        • 9.3.1.2.2. By Workflow
        • 9.3.1.2.3. By End User
    • 9.3.2. Argentina Next Generation Sequencing Services Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Service
        • 9.3.2.2.2. By Workflow
        • 9.3.2.2.3. By End User
    • 9.3.3. Colombia Next Generation Sequencing Services Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Service
        • 9.3.3.2.2. By Workflow
        • 9.3.3.2.3. By End User

10. Middle East and Africa Next Generation Sequencing Services Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Service
    • 10.2.2. By Workflow
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Next Generation Sequencing Services Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Service
        • 10.3.1.2.2. By Workflow
        • 10.3.1.2.3. By End User
    • 10.3.2. Saudi Arabia Next Generation Sequencing Services Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Service
        • 10.3.2.2.2. By Workflow
        • 10.3.2.2.3. By End User
    • 10.3.3. UAE Next Generation Sequencing Services Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Service
        • 10.3.3.2.2. By Workflow
        • 10.3.3.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Global Next Generation Sequencing Services Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Business Overview
  • 15.2. Service Offerings
  • 15.3. Recent Developments
  • 15.4. Key Personnel
  • 15.5. SWOT Analysis
    • 15.5.1. Quest Diagnostics Incorporated
    • 15.5.2. Applied Biological Materials, Inc.
    • 15.5.3. Novogene Co, Ltd.
    • 15.5.4. Azenta Life Sciences (GENEWIZ)
    • 15.5.5. NanoString Technologies, Inc.
    • 15.5.6. Illumina, Inc.
    • 15.5.7. PacBio, Inc.
    • 15.5.8. Gene by Gene Ltd
    • 15.5.9. Lucigen Corporation

16. Strategic Recommendations